Search research articles
Contact Us
Filters
Showing results (171-180 of 195) with videos related to
Page
of 20
Sort By:
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Cell Host & Microbe
|
May 21, 2021
Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir
Jyothi K Rajashekar, Jonathan Richard, Jagadish Beloor, et al.
Biorxiv : the Preprint Server for Biology
|
August 10, 2021
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia
Mehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
The Journal of Infectious Diseases
|
November 30, 2023
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia
Mehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2024
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC
Jonathan Richard, Michael W Grunst, Ling Niu, et al.
Microbiology Spectrum
|
June 22, 2022
Correction for Valcourt et al., "Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays"
Emelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Cell Reports
|
February 26, 2022
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports
|
October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Cell Reports
|
June 22, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 195) with videos related to
Sort By:
Page
of 20
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Cell Host & Microbe
|
May 21, 2021
Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir
Jyothi K Rajashekar, Jonathan Richard, Jagadish Beloor, et al.
Biorxiv : the Preprint Server for Biology
|
August 10, 2021
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia
Mehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
The Journal of Infectious Diseases
|
November 30, 2023
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia
Mehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2024
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC
Jonathan Richard, Michael W Grunst, Ling Niu, et al.
Microbiology Spectrum
|
June 22, 2022
Correction for Valcourt et al., "Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays"
Emelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Cell Reports
|
February 26, 2022
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports
|
October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Cell Reports
|
June 22, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Page
of 20